The New NIH Guidelines on Asthma in Pregnancy

Home

Category: CME
Sub-Category: ALRG/OBGY
Date: 5/27/2006
Time:4:00 PM to 4:45 PM
Facility: Moscone Convention Center
Location: E-134
Description: At the conclusion of this presentation, participants will be able to:
Explain the clinical interrelationships between asthma and pregnancy
Manage asthma in the pregnant patient based on the updated National Asthma Education and Prevention Program (NAEPP) guidelines

Asthma is the most common potentially serious medical problem to complicate pregnancy. Asthma course may change during pregnancy, worsening in about one-third of patients. Maternal asthma may increase the risks of perinatal complications, but adequate control of asthma reduces these risks. The four
elements of management described by the NAEPP updated guidelines are 1) Assessment and monitoring (the asthma and the fetus), 2) Identification and control of asthma triggers, 3) Patient education, including self-management education, and 4)Pharmacologic therapy. Inhaled steroids are the treatment of choice for all levels of persistent asthma during pregnancy. Long-acting beta agonists should be added if adequate control is not achieved by inhaled steroids alone.
Speaker(s): Michael Schatz M.D., M.S., FAAAAI 


View Syllabus      

 

Copyright 1998-2006.  American Academy of Physician Assistants.  All rights reserved.